Update: SpaceX postponed Friday's launch. The news liftoff is expected Saturday, November 18, 2023 with a 20-minute window opening at 8:00 a.m. ET.

By Marcia Dunn

SpaceX is aiming for another test flight of its mega rocket on Friday after getting final approval from federal regulators.

The first launch of Starship ended in an explosion minutes after lifting off from South Texas in April.

The Federal Aviation Administration issued its license Wednesday, noting that SpaceX has met safety, environmental and other requirements to launch again. Elon Musk's rocket company said it was targeting Friday morning.

After the self-destruct system blew up the rocket over the Gulf of Mexico, SpaceX made dozens of improvements to the nearly 400-foot (121-meter) rocket and to the launch pad, which ended up with a large crater beneath it.

SpaceX has a $3 billion NASA contract to land astronauts on the lunar surface as early as 2025, using the spacecraft.

A month ago, the FAA completed its safety review of the upcoming Starship launch. It needed more time to wrap up its environmental review. No one was injured in the first attempt, but the pad was heavily damaged as the rocket's 33 main engines ignited at liftoff.

The U.S. Fish and Wildlife Service later reported that concrete chunks, steel sheets and other objects were hurled thousands of feet (hundreds of meters) from the pad. It also said a plume of pulverized concrete sent material several miles (up to 10 kilometers) away.

Wildlife and environmental groups sued the FAA over what they considered to be the FAA’s failure to fully consider the environmental impacts of the Starship program near Boca Chica Beach.

Plans call for the test flight to last 1 /1/2 hours and fall short of a full orbit of Earth. The spacecraft would go eastward, passing over the Atlantic, Indian and Pacific oceans before ditching near Hawaii. Nothing of value will be on board.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Updated November 17, 2023 at 8:53 a.m. ET with time for new launch attempt.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More